Media Articles Related to Klaron (Sulfacetamide Topical)
Acne's Silver Lining: Slower Aging of the Skin?
Source: MedicineNet Acne Specialty [2016.09.30]
Title: Acne's Silver Lining: Slower Aging of the Skin?
Category: Health News
Created: 9/29/2016 12:00:00 AM
Last Editorial Review: 9/30/2016 12:00:00 AM
Hormonal Acne: Causes, Types, and Treatment
Source: Endocrinology News From Medical News Today [2016.09.26]
Acne is sometimes called hormonal acne because of how the skin problem develops in response to hormonal changes. Learn about its treatment and symptoms.
Acne Care Pictures: Skin Care Dos and Don'ts
Source: MedicineNet Acne Specialty [2016.09.12]
Title: Acne Care Pictures: Skin Care Dos and Don'ts
Created: 8/1/2012 12:00:00 AM
Last Editorial Review: 9/12/2016 12:00:00 AM
Acne Treatment Differin Gel Approved for OTC Use
Source: MedicineNet adapalene Specialty [2016.07.12]
Title: Acne Treatment Differin Gel Approved for OTC Use
Category: Health News
Created: 7/11/2016 12:00:00 AM
Last Editorial Review: 7/12/2016 12:00:00 AM
FDA OKs Non-Prescription Use of Acne Drug
Source: MedicineNet adapalene Specialty [2016.07.11]
Title: FDA OKs Non-Prescription Use of Acne Drug
Category: Health News
Created: 7/8/2016 12:00:00 AM
Last Editorial Review: 7/11/2016 12:00:00 AM
Published Studies Related to Klaron (Sulfacetamide Topical)
Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea. [2005.06]
Topical metronidazole and combination sodium sulfacetamide and sulfur commonly are used to treat rosacea. Recently, the relative efficacy and safety of sodium sulfacetamide 10% and sulfur 5% cream with sunscreens (Rosac Cream) (n = 75) and metronidazole 0.75% cream (Metrocream) (n = 77) were compared in an investigator-blinded, randomized, parallel-group study at 6 sites...
Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxide. [2009.09]
CONCLUSIONS: Knowledge of the chemical reaction between benzoyl peroxide and sulfacetamide and dapsone will help minimize the occurrence of this interaction on our patients' skin.
Treatment of papulopustular rosacea with sodium sulfacetamide 10%/sulfur 5% emollient foam. [2009.03]
Acne rosacea is a chronic cutaneous disorder affecting as many as 14 million Americans.The high patient satisfaction ratings for SSSE foam suggest that the product may improve long-term compliance rates, with the potential to yield more favorable clinical outcomes.
Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations. [2004.01]
The combination of sodium sulfacetamide and sulfur is unique in the rosacea armamentarium because of its dual use as topical therapy and therapeutic cleanser. Several formulations of sulfacetamide 10% and sulfur 5% are now available as topical lotions and cleansers.The sulfacetamide/sulfur cleansers serve as adjunctive therapy by providing additive effects to other topical and oral therapies for rosacea with favorable tolerability and cosmetic appeal.
Measurement of aqueous humor flow following scleral injection of sulfacetamide as marker: effect of methazolamide, timolol, and pilocarpine. [1989.01]
A simple technique for rapid determination of the flow of aqueous humor (AH) in rabbits is described. Data from control eyes and eyes treated with known inhibitors of aqueous humor production are presented as evidence of the suitability of the technique for comparing the influence of other drugs on aqueous flow.
Clinical Trials Related to Klaron (Sulfacetamide Topical)
Effects of Hyperbaric Oxygen Therapy on Surgical Wound Healing [Enrolling by invitation]
The aim of this study is to test the effect of Hyperbaric Oxygen Therapy) HBOT (100% oxygen;
2. 0 ATA; 90 minute total exposure) and compare against a hyperbaric sham treatment (HBST)
(patient's breathing room air; 2. 0 ATA; 90 minute exposure) in reducing edema and
ecchymosis. HBOT will be applied as a single pre-operative and a single post-operative
treatment for patients undergoing eyelid surgery. Briefly, patients will be exposed to HBOT
2-4 hours prior to undergoing surgery, 2-4 hours post-surgery and healing will be assessed
at day 3, 10, 21, 30 & 90 days after surgery. Edema and ecchymosis will be assessed in a
time series to determine the extent that HBOT reduces these clinical signs. The primary
null hypothesis to test will be that no differences in scores will exist between treatment
and control at day 3, 10 & 21 post-surgery. A secondary null hypothesis to test is the time
required to change a score will be no different between the two groups.
HBOT=hyperbaric oxygen therapy; HBST=hyperbaric sham treatment
Patients Response to Early Switch To Oral:Osteomyelitis Study [Not yet recruiting]
Based on the current literature, investigators hypothesize that patients with osteomyelitis
who are treated with the standard approach of intravenous antibiotics for the full duration
of therapy will have the same clinical outcomes as patients treated with the experimental
approach of intravenous antibiotics with early switch to oral antibiotics.
The primary objective of this study is to compare patients with osteomyelitis treated with
the standard approach of intravenous antibiotics for the full duration of therapy versus
patients treated with intravenous antibiotics with an early switch to oral antibiotics in
relation to clinical outcomes at 12 months after discontinuation of antibiotic therapy.
Secondary objectives of the study include the evaluation of adverse events related to the
use of antibiotics as well as the cost of care evaluated from the hospital perspective.
Intraductal Meibomian Gland Probing Trial [Active, not recruiting]
In this research study, the investigators are looking at the effects of Meibomian Gland
Probing (MGP) versus a sham (fake) procedure in patients with refractory MGD who have
already tried traditional management with no success in resolving their clinical signs (as
seen by their ophthalmologist) or their symptoms.
The investigators are also evaluating the effects of using two (2) post-procedural
medication treatments: Blephamide or GenTeal PM Night-Time to determine if treatment after
the MGP procedure has an effect on its outcome.
The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy [Terminated]
This is a pilot, randomized, self-controlled study of the effects of intratympanic sodium
thiosulfate (STS) on the degree of hearing loss in patients receiving cisplatin therapy.
Sodium thiosulfate is an inactive ingredient contained in sulfacetamide ophthalmic solution
which is used routinely as an otic solution delivered to the middle ear space.
The hypothesis of this study is that local administration of sodium thiosulfate (STS) will
result in improved hearing compared to ears not receiving the study drug in patients
receiving systemic cisplatin therapy.
ORCA - Oracea« for Rosacea: A Community-based Assessment [Completed]
The objective of this study is to assess the effectiveness, safety, subject satisfaction and
quality of life with Oracea« when used as monotherapy or as add-on therapy to existing
topical regimens for the treatment of rosacea.